LV-EF1α-Venus-T2A-AkaLuc-IRES-Neo

$468.00

Add to Cart:

  • Catalog #: SL100339
  • Unit Size: 2 x 25 µL (>10^9 TU/mL)

Please Choose:



Pre-made recombinant lentivirus | LV-EF1α-Venus-T2A-AkaLuc-IRES-Neo | LV-EF1A-Venus-T2A-AkaLuc-IRES-Neo | EF1α-Venus-T2A-AkaLuc-IRES-Neo Lentivirus

Product Category: Pre-made recombinant lentivirus | LV-EF1α-Venus-T2A-AkaLuc-IRES-Neo | LV-EF1A-Venus-T2A-AkaLuc-IRES-Neo | EF1α-Venus-T2A-AkaLuc-IRES-Neo Lentivirus

Description: LV-EF1α-Venus-T2A-AkaLuc-IRES-Neo is a pre-made lentiviral vector that expresses reporter Venus and AkaLuc via a T2A linker under the control of the EF1α promoter, with co-expression of neomycin resistance via an IRES cassette. AkaLuc is an engineered luciferase optimized for use with the substrate AkaLumine-HCl, providing significantly higher in vivo sensitivity (approximately 10–100× brighter than firefly luciferase in mice) and near-infrared emission (~675 nm) for deeper tissue penetration and reduced autofluorescence. The virus is supplied in a ready-to-use format.

Titer: > 1x10TU/mL

Selection Antibiotic: Puromycin


Purity*: In vivo grade and OK for both in vitro tissue culture infection and in vivo injection

Size: 2 x 25 µL (Std Pack)

Storage Buffer: PBS

Infection Protocol: 


Transfer Vector Map:
Pre-made recombinant lentivirus | LV-EF1α-Venus-T2A-AkaLuc-IRES-Neo | LV-EF1A-Venus-T2A-AkaLuc-IRES-Neo | EF1α-Venus-T2A-AkaLuc-IRES-Neo Lentivirus


* Concentrated via PEG precipitation followed by ultra-centrifugation at 25000 rpm


 




Copyright © 2025 SignaGen Laboratories. All Rights Reserved..